Which has stronger valuation and earnings, RVTY or SHC?

Revvity has higher revenue and earnings than Sotera Health. Sotera Health is trading at a lower price-to-earnings ratio than Revvity, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Revvity $2.86B 5.95 $241.20M $2.10 72.52 Sotera Health $1.16B 4.37 $77.94M $0.57 31.28

Is RVTY or SHC more profitable?

Sotera Health has a net margin of 13.44% compared to Revvity's net margin of 8.16%. Sotera Health's return on equity of 40.12% beat Revvity's return on equity. Company Net Margins Return on Equity Return on Assets Revvity 8.16% 8.34% 5.01% Sotera Health 13.44% 40.12% 7.55%

Does the media favor RVTY or SHC?

In the previous week, Revvity had 10 more articles in the media than Sotera Health. MarketBeat recorded 11 mentions for Revvity and 1 mentions for Sotera Health. Sotera Health's average media sentiment score of 1.54 beat Revvity's score of 0.42 indicating that Sotera Health is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Revvity 3 Very Positive mention(s) 2 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Sotera Health 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive

Which has stronger valuation & earnings, MEDP or SHC?

Medpace has higher revenue and earnings than Sotera Health. Sotera Health is trading at a lower price-to-earnings ratio than Medpace, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Medpace $2.78B 6.05 $451.12M $17.06 35.33 Sotera Health $1.16B 4.37 $77.94M $0.57 31.28

Is MEDP or SHC more profitable?

Medpace has a net margin of 17.67% compared to Sotera Health's net margin of 13.44%. Medpace's return on equity of 110.15% beat Sotera Health's return on equity. Company Net Margins Return on Equity Return on Assets Medpace 17.67% 110.15% 24.84% Sotera Health 13.44% 40.12% 7.55%

Does the media favor MEDP or SHC?

In the previous week, Medpace had 6 more articles in the media than Sotera Health. MarketBeat recorded 7 mentions for Medpace and 1 mentions for Sotera Health. Sotera Health's average media sentiment score of 1.54 beat Medpace's score of 0.42 indicating that Sotera Health is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Medpace 4 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Sotera Health 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive

Does the media favor SHC or CRL?

In the previous week, Charles River Laboratories International had 22 more articles in the media than Sotera Health. MarketBeat recorded 23 mentions for Charles River Laboratories International and 1 mentions for Sotera Health. Sotera Health's average media sentiment score of 1.54 beat Charles River Laboratories International's score of 0.73 indicating that Sotera Health is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Sotera Health 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Charles River Laboratories International 3 Very Positive mention(s) 3 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has higher earnings & valuation, ICLR or SHC?

Icon has higher revenue and earnings than Sotera Health. Sotera Health is trading at a lower price-to-earnings ratio than Icon, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Icon $8.25B 1.53 $229.34M $4.26 38.62 Sotera Health $1.16B 4.37 $77.94M $0.57 31.28

Is ICLR or SHC more profitable?

Sotera Health has a net margin of 13.44% compared to Icon's net margin of 3.99%. Sotera Health's return on equity of 40.12% beat Icon's return on equity. Company Net Margins Return on Equity Return on Assets Icon 3.99% 8.02% 4.56% Sotera Health 13.44% 40.12% 7.55%

Does the media favor ICLR or SHC?

In the previous week, Icon had 1 more articles in the media than Sotera Health. MarketBeat recorded 2 mentions for Icon and 1 mentions for Sotera Health. Sotera Health's average media sentiment score of 1.54 beat Icon's score of 0.67 indicating that Sotera Health is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Icon 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Sotera Health 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive

Which has higher earnings and valuation, SHC or TECH?

Bio-Techne has higher revenue and earnings than Sotera Health. Sotera Health is trading at a lower price-to-earnings ratio than Bio-Techne, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Sotera Health $1.16B 4.37 $77.94M $0.57 31.28 Bio-Techne $1.22B 9.35 $181.86M $1.15 63.00

Is SHC or TECH more profitable?

Bio-Techne has a net margin of 14.97% compared to Sotera Health's net margin of 13.44%. Sotera Health's return on equity of 40.12% beat Bio-Techne's return on equity. Company Net Margins Return on Equity Return on Assets Sotera Health 13.44% 40.12% 7.55% Bio-Techne 14.97% 13.23% 10.61%

Does the media refer more to SHC or TECH?

In the previous week, Bio-Techne had 4 more articles in the media than Sotera Health. MarketBeat recorded 5 mentions for Bio-Techne and 1 mentions for Sotera Health. Sotera Health's average media sentiment score of 1.54 beat Bio-Techne's score of 0.64 indicating that Sotera Health is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Sotera Health 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Bio-Techne 2 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Sotera Health (SHC) Competitors

$18.06 +0.23 (+1.29%)

Closing price 04:00 PM Eastern

Extended Trading

$18.06 0.00 (-0.03%)

As of 07:30 PM Eastern

Compare

SHC vs. RVTY, MEDP, CRL, ICLR, and TECH

Should you buy Sotera Health stock or one of its competitors? Sotera Health's main competitors and comparable companies include Revvity (RVTY), Medpace (MEDP), Charles River Laboratories International (CRL), Icon (ICLR), and Bio-Techne (TECH). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "life sciences tools & services" industry.

How does Sotera Health compare to Revvity?

Revvity (NYSE:RVTY) and Sotera Health (NASDAQ:SHC) are both healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, media sentiment, earnings, dividends, profitability, valuation and risk.

Revvity currently has a consensus price target of $120.50, indicating a potential downside of 20.87%. Sotera Health has a consensus price target of $21.50, indicating a potential upside of 20.58%. Given Sotera Health's stronger consensus rating and higher possible upside, analysts plainly believe Sotera Health is more favorable than Revvity.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Revvity	0 Sell rating(s)	14 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.26
Sotera Health	0 Sell rating(s)	3 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.73

Revvity has a beta of 1.06, indicating that its share price is 6% more volatile than the broader market. Comparatively, Sotera Health has a beta of 1.85, indicating that its share price is 85% more volatile than the broader market.

Sotera Health has a net margin of 13.44% compared to Revvity's net margin of 8.16%. Sotera Health's return on equity of 40.12% beat Revvity's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Revvity	8.16%	8.34%	5.01%
Sotera Health	13.44%	40.12%	7.55%

In the previous week, Revvity had 10 more articles in the media than Sotera Health. MarketBeat recorded 11 mentions for Revvity and 1 mentions for Sotera Health. Sotera Health's average media sentiment score of 1.54 beat Revvity's score of 0.42 indicating that Sotera Health is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Revvity	3 Very Positive mention(s)	2 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Sotera Health	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

Revvity has higher revenue and earnings than Sotera Health. Sotera Health is trading at a lower price-to-earnings ratio than Revvity, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Revvity	$2.86B	5.95	$241.20M	$2.10	72.52
Sotera Health	$1.16B	4.37	$77.94M	$0.57	31.28

86.7% of Revvity shares are owned by institutional investors. Comparatively, 91.0% of Sotera Health shares are owned by institutional investors. 0.9% of Revvity shares are owned by company insiders. Comparatively, 15.4% of Sotera Health shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Summary

Sotera Health beats Revvity on 10 of the 16 factors compared between the two stocks.

How does Sotera Health compare to Medpace?

Medpace (NASDAQ:MEDP) and Sotera Health (NASDAQ:SHC) are both healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their valuation, analyst recommendations, earnings, media sentiment, dividends, profitability, risk and institutional ownership.

78.0% of Medpace shares are owned by institutional investors. Comparatively, 91.0% of Sotera Health shares are owned by institutional investors. 20.5% of Medpace shares are owned by company insiders. Comparatively, 15.4% of Sotera Health shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Medpace has a net margin of 17.67% compared to Sotera Health's net margin of 13.44%. Medpace's return on equity of 110.15% beat Sotera Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Medpace	17.67%	110.15%	24.84%
Sotera Health	13.44%	40.12%	7.55%

In the previous week, Medpace had 6 more articles in the media than Sotera Health. MarketBeat recorded 7 mentions for Medpace and 1 mentions for Sotera Health. Sotera Health's average media sentiment score of 1.54 beat Medpace's score of 0.42 indicating that Sotera Health is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Medpace	4 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Sotera Health	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

Medpace has a beta of 1.18, meaning that its share price is 18% more volatile than the broader market. Comparatively, Sotera Health has a beta of 1.85, meaning that its share price is 85% more volatile than the broader market.

Medpace presently has a consensus target price of $607.73, indicating a potential upside of 0.83%. Sotera Health has a consensus target price of $21.50, indicating a potential upside of 20.58%. Given Sotera Health's stronger consensus rating and higher possible upside, analysts clearly believe Sotera Health is more favorable than Medpace.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Medpace	0 Sell rating(s)	10 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.23
Sotera Health	0 Sell rating(s)	3 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.73

Medpace has higher revenue and earnings than Sotera Health. Sotera Health is trading at a lower price-to-earnings ratio than Medpace, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Medpace	$2.78B	6.05	$451.12M	$17.06	35.33
Sotera Health	$1.16B	4.37	$77.94M	$0.57	31.28

Summary

Medpace beats Sotera Health on 10 of the 16 factors compared between the two stocks.

How does Sotera Health compare to Charles River Laboratories International?

Sotera Health (NASDAQ:SHC) and Charles River Laboratories International (NYSE:CRL) are both healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their media sentiment, risk, earnings, institutional ownership, dividends, analyst recommendations, valuation and profitability.

In the previous week, Charles River Laboratories International had 22 more articles in the media than Sotera Health. MarketBeat recorded 23 mentions for Charles River Laboratories International and 1 mentions for Sotera Health. Sotera Health's average media sentiment score of 1.54 beat Charles River Laboratories International's score of 0.73 indicating that Sotera Health is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Sotera Health	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
Charles River Laboratories International	3 Very Positive mention(s)	3 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

91.0% of Sotera Health shares are held by institutional investors. Comparatively, 98.9% of Charles River Laboratories International shares are held by institutional investors. 15.4% of Sotera Health shares are held by insiders. Comparatively, 1.3% of Charles River Laboratories International shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Sotera Health has a net margin of 13.44% compared to Charles River Laboratories International's net margin of -5.96%. Sotera Health's return on equity of 40.12% beat Charles River Laboratories International's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Sotera Health	13.44%	40.12%	7.55%
Charles River Laboratories International	-5.96%	15.75%	6.51%

Sotera Health has higher earnings, but lower revenue than Charles River Laboratories International. Charles River Laboratories International is trading at a lower price-to-earnings ratio than Sotera Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Sotera Health	$1.16B	4.37	$77.94M	$0.57	31.28
Charles River Laboratories International	$4.02B	3.54	-$144.34M	-$4.85	N/A

Sotera Health currently has a consensus price target of $21.50, suggesting a potential upside of 20.58%. Charles River Laboratories International has a consensus price target of $300.11, suggesting a potential upside of 0.83%. Given Sotera Health's higher probable upside, equities analysts plainly believe Sotera Health is more favorable than Charles River Laboratories International.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sotera Health	0 Sell rating(s)	3 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.73
Charles River Laboratories International	1 Sell rating(s)	2 Hold rating(s)	12 Buy rating(s)	2 Strong Buy rating(s)	2.88

Sotera Health has a beta of 1.85, indicating that its stock price is 85% more volatile than the broader market. Comparatively, Charles River Laboratories International has a beta of 1.4, indicating that its stock price is 40% more volatile than the broader market.

Summary

Sotera Health beats Charles River Laboratories International on 11 of the 17 factors compared between the two stocks.

How does Sotera Health compare to Icon?

Icon (NASDAQ:ICLR) and Sotera Health (NASDAQ:SHC) are both healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their risk, analyst recommendations, valuation, earnings, institutional ownership, profitability, media sentiment and dividends.

Sotera Health has a net margin of 13.44% compared to Icon's net margin of 3.99%. Sotera Health's return on equity of 40.12% beat Icon's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Icon	3.99%	8.02%	4.56%
Sotera Health	13.44%	40.12%	7.55%

Icon presently has a consensus target price of $172.40, suggesting a potential upside of 4.80%. Sotera Health has a consensus target price of $21.50, suggesting a potential upside of 20.58%. Given Sotera Health's stronger consensus rating and higher possible upside, analysts clearly believe Sotera Health is more favorable than Icon.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Icon	2 Sell rating(s)	8 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	2.39
Sotera Health	0 Sell rating(s)	3 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.73

95.6% of Icon shares are held by institutional investors. Comparatively, 91.0% of Sotera Health shares are held by institutional investors. 44.0% of Icon shares are held by company insiders. Comparatively, 15.4% of Sotera Health shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Icon has a beta of 1.24, suggesting that its stock price is 24% more volatile than the broader market. Comparatively, Sotera Health has a beta of 1.85, suggesting that its stock price is 85% more volatile than the broader market.

Icon has higher revenue and earnings than Sotera Health. Sotera Health is trading at a lower price-to-earnings ratio than Icon, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Icon	$8.25B	1.53	$229.34M	$4.26	38.62
Sotera Health	$1.16B	4.37	$77.94M	$0.57	31.28

In the previous week, Icon had 1 more articles in the media than Sotera Health. MarketBeat recorded 2 mentions for Icon and 1 mentions for Sotera Health. Sotera Health's average media sentiment score of 1.54 beat Icon's score of 0.67 indicating that Sotera Health is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Icon	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Sotera Health	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

Summary

Sotera Health beats Icon on 9 of the 17 factors compared between the two stocks.

How does Sotera Health compare to Bio-Techne?

Sotera Health (NASDAQ:SHC) and Bio-Techne (NASDAQ:TECH) are both healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, profitability, institutional ownership, valuation, earnings, dividends, analyst recommendations and risk.

In the previous week, Bio-Techne had 4 more articles in the media than Sotera Health. MarketBeat recorded 5 mentions for Bio-Techne and 1 mentions for Sotera Health. Sotera Health's average media sentiment score of 1.54 beat Bio-Techne's score of 0.64 indicating that Sotera Health is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Sotera Health	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
Bio-Techne	2 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

91.0% of Sotera Health shares are held by institutional investors. Comparatively, 99.0% of Bio-Techne shares are held by institutional investors. 15.4% of Sotera Health shares are held by company insiders. Comparatively, 1.3% of Bio-Techne shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Sotera Health has a beta of 1.85, meaning that its stock price is 85% more volatile than the broader market. Comparatively, Bio-Techne has a beta of 1.3, meaning that its stock price is 30% more volatile than the broader market.

Bio-Techne has a net margin of 14.97% compared to Sotera Health's net margin of 13.44%. Sotera Health's return on equity of 40.12% beat Bio-Techne's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Sotera Health	13.44%	40.12%	7.55%
Bio-Techne	14.97%	13.23%	10.61%

Sotera Health currently has a consensus price target of $21.50, indicating a potential upside of 20.58%. Bio-Techne has a consensus price target of $68.92, indicating a potential downside of 4.87%. Given Sotera Health's stronger consensus rating and higher possible upside, analysts clearly believe Sotera Health is more favorable than Bio-Techne.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sotera Health	0 Sell rating(s)	3 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.73
Bio-Techne	0 Sell rating(s)	15 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.12

Bio-Techne has higher revenue and earnings than Sotera Health. Sotera Health is trading at a lower price-to-earnings ratio than Bio-Techne, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Sotera Health	$1.16B	4.37	$77.94M	$0.57	31.28
Bio-Techne	$1.22B	9.35	$181.86M	$1.15	63.00

Summary

Bio-Techne beats Sotera Health on 9 of the 16 factors compared between the two stocks.

Get Sotera Health News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SHC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

SHC vs. The Competition

Export

Metric	Sotera Health	Life Sciences Tools & Services Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$5.09B	$10.42B	$7.16B	$13.21B
Dividend Yield	N/A	1.45%	2.53%	20.71%
P/E Ratio	31.68	25.14	202.00	20.27
Price / Sales	4.43	106.97	580.96	87.35
Price / Cash	13.95	27.23	76.38	53.09
Price / Book	8.48	6.49	11.21	6.34
Net Income	$77.94M	$56.67B	$3.50B	$381.90M
7 Day Performance	-0.88%	-1.09%	-0.84%	-1.39%
1 Month Performance	-1.47%	8.84%	-5.42%	-4.31%
1 Year Performance	14.45%	28.78%	4.38%	-0.35%

Sotera Health Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
SHC Sotera Health	4.0353 of 5 stars	$18.06 +1.3%	$21.50 +19.0%	+11.4%	$5.09B	$1.16B	31.68	3,000	Analyst Upgrade
RVTY Revvity	2.5837 of 5 stars	$153.33 -2.6%	$116.57 -24.0%	+65.7%	$17.11B	$2.86B	73.02	11,000	Analyst Forecast
MEDP Medpace	3.0019 of 5 stars	$602.90 -2.8%	$602.27 -0.1%	+13.5%	$16.83B	$2.78B	35.34	6,200	Analyst Forecast
CRL Charles River Laboratories International	2.6132 of 5 stars	$305.95 -1.6%	$300.11 -1.9%	+71.5%	$14.61B	$4.00B	N/A	19,700	Insider Trade Analyst Revision High Trading Volume
ICLR Icon	3.1759 of 5 stars	$161.69 -3.9%	$172.40 +6.6%	-11.8%	$12.38B	$8.29B	37.96	40,100	News Coverage Analyst Upgrade

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:SHC) was last updated on 10/9/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Sotera Health (SHC) Competitors

SHC vs. RVTY, MEDP, CRL, ICLR, and TECH

How does Sotera Health compare to Revvity?

Summary

How does Sotera Health compare to Medpace?

Summary

How does Sotera Health compare to Charles River Laboratories International?

Summary

How does Sotera Health compare to Icon?

Summary

How does Sotera Health compare to Bio-Techne?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

SHC vs. The Competition

Sotera Health Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Sotera Health (SHC) Competitors

SHC vs. RVTY, MEDP, CRL, ICLR, and TECH

How does Sotera Health compare to Revvity?

Do analysts prefer RVTY or SHC?

Which has more risk and volatility, RVTY or SHC?

Is RVTY or SHC more profitable?

Does the media favor RVTY or SHC?

Which has stronger valuation and earnings, RVTY or SHC?

Do insiders and institutionals believe in RVTY or SHC?

Summary

How does Sotera Health compare to Medpace?

Do institutionals and insiders have more ownership in MEDP or SHC?

Is MEDP or SHC more profitable?

Does the media favor MEDP or SHC?

Which has more volatility & risk, MEDP or SHC?

Do analysts prefer MEDP or SHC?

Which has stronger valuation & earnings, MEDP or SHC?

Summary

How does Sotera Health compare to Charles River Laboratories International?

Does the media favor SHC or CRL?

Do institutionals and insiders believe in SHC or CRL?

Is SHC or CRL more profitable?

Which has higher earnings and valuation, SHC or CRL?

Do analysts rate SHC or CRL?

Which has more risk & volatility, SHC or CRL?

Summary

How does Sotera Health compare to Icon?

Is ICLR or SHC more profitable?

Do analysts recommend ICLR or SHC?

Do institutionals and insiders hold more shares of ICLR or SHC?

Which has more volatility and risk, ICLR or SHC?

Which has higher earnings & valuation, ICLR or SHC?

Does the media favor ICLR or SHC?

Summary

How does Sotera Health compare to Bio-Techne?

Does the media refer more to SHC or TECH?

Do institutionals & insiders believe in SHC or TECH?

Which has more risk & volatility, SHC or TECH?

Is SHC or TECH more profitable?

Do analysts prefer SHC or TECH?

Which has higher earnings and valuation, SHC or TECH?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

SHC vs. The Competition

Sotera Health Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools